4.7 Article

A novel alginate/gelatin sponge combined with curcumin-loaded electrospun fibers for postoperative rapid hemostasis and prevention of tumor recurrence

Journal

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 182, Issue -, Pages 1339-1350

Publisher

ELSEVIER
DOI: 10.1016/j.ijbiomac.2021.05.074

Keywords

Surgical resection; Alginate; gelatin sponge; Curcumin-loaded electrospun fibers; Hemostasis; Tumor recurrence

Funding

  1. National Natural Science Foundation of China [82073794/H3408]
  2. Open Foundation of the State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process [SKL2020Z0208]

Ask authors/readers for more resources

The novel alginate/gelatin sponge combined with curcumin-loaded electrospun fibers shows excellent hemostatic properties and effective prevention of tumor recurrence. This dual functional sponge was safe to implant in the body and did not cause toxicity to normal tissues and organs, representing a promising adjuvant strategy for cancer surgical treatment.
Surgical resection of the tumor remains the preferred treatment for most solid tumors at an early stage, but surgical treatment often leads to massive bleeding and residual tumor cells. Therefore, a novel alginate/gelatin sponge combined with curcumin-loaded electrospun fibers (CFAGS) for rapid hemostasis and prevention of tumor recurrence was prepared by using an electrospinning and interpenetrating polymer network (IPN) strategy. The present results show that alginate/gelatin sponge display excellent hemostatic properties and possess more advantages than commercial gelatin hemostasis sponge. More importantly, CFAGS could control the release of curcumin, inducing curcumin to accumulate at the surgical site of the tumor, thereby inhibiting local tumor recurrence in the subcutaneous postoperative recurrence model. In addition, the sponge was safe to implant in the body and did not cause toxicity to normal tissues and organs. This approach represents a new strategy to implant a dual functional sponge at the postoperative site as an adjuvant to the surgical treatment of cancer. (c) 2021 Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available